Tim ClarkClinical Development Consultant
Dr Clark is a Clinical Development Consultant at ICON Clinical Research GmbH. Dr Clark is part of the Drug Development Services group, which provides strategic drug development advice to customers and internal teams. Dr Clark gained his PhD in clinical trial methodology at the Institute for Medical Informatics, Biometry and Epidemiology (IBE), Ludwig-Maximilians-University, Munich. Prior to joining ICON in 2009, Dr Clark worked in clinical research and regulatory affairs for large French and American pharmaceutical companies and as an independent consultant advising on a range of drug development issues. He has worked on small molecule and biological (including biosimilars) programmes indicated for cancer as well as CNS, autoimmune, cardiovascular and infectious diseases. Dr Clark has published on clinical study design and sample size determination in peer reviewed journals and is currently a Visiting Researcher in clinical trial methodology at the IBE, Ludwig-Maximilians-University, Munich.